Buys | $1,680,288 | 4 | 100 |
Sells | $0 | 0 | 0 |
Thermopylae Holdings Ltd. | 10 percent owner | 2 | $1.48M | 0 | $0 | $1.48M |
Montalbano John S. | director | 2 | $198,068 | 0 | $0 | $198,068 |
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is …
Over the last 12 months, insiders at AbCellera Biologics Inc. have bought $1.68M and sold $0 worth of AbCellera Biologics Inc. stock.
On average, over the past 5 years, insiders at AbCellera Biologics Inc. have bought $30.23M and sold $394.03M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Thermopylae Holdings Ltd. (10 percent owner) — $1.48M. Montalbano John S. (director) — $198,068.
The last purchase of 343,631 shares for transaction amount of $742,243 was made by Thermopylae Holdings Ltd. (10 percent owner) on 2025‑03‑11.
2025-03-11 | Thermopylae Holdings Ltd. | 10 percent owner | 343,631 0.1117% | $2.16 | $742,243 | +7.62% | ||
2025-03-10 | Montalbano John S. | director | 25,000 0.0088% | $2.30 | $57,500 | +7.95% | ||
2025-03-06 | Montalbano John S. | director | 60,000 0.0198% | $2.34 | $140,568 | -1.89% | ||
2024-08-29 | Thermopylae Holdings Ltd. | 10 percent owner | 283,516 0.0993% | $2.61 | $739,977 | +10.67% | ||
2023-11-08 | Montalbano John S. | director | 10,000 0.0037% | $4.46 | $44,600 | -7.89% | ||
2023-11-06 | Montalbano John S. | director | 20,000 0.0071% | $4.64 | $92,800 | -13.76% | ||
2023-09-22 | Hayden Michael R | director | 20,000 0.0066% | $4.91 | $98,200 | -14.30% | ||
2023-09-12 | Lecault Veronique | Chief Operating Officer | 20,000 0.007% | $5.19 | $103,800 | -15.56% | ||
2023-08-08 | Hayden Michael R | director | 30,000 0.0104% | $5.90 | $177,000 | -23.77% | ||
2023-05-26 | Thermopylae Holdings Ltd. | 10 percent owner | 153,000 0.051% | $6.52 | $997,728 | -26.25% | ||
2023-05-26 | Booth Andrew | Chief Financial Officer | 14,500 0.0051% | $6.85 | $99,325 | -26.25% | ||
2022-12-16 | Thermopylae Holdings Ltd. | director | 85,102 0.0295% | $10.10 | $859,249 | -33.50% | ||
2022-08-19 | Thermopylae Holdings Ltd. | 10 percent owner | 200,000 0.0702% | $11.46 | $2.29M | -20.94% | ||
2022-06-14 | Thermopylae Holdings Ltd. | 10 percent owner | 9,173 0.0029% | $8.05 | $73,842 | +16.48% | ||
2022-06-13 | Thermopylae Holdings Ltd. | 10 percent owner | 54,915 0.0189% | $8.03 | $441,066 | +25.00% | ||
2022-06-06 | Thermopylae Holdings Ltd. | 10 percent owner | 64,545 0.0222% | $7.50 | $483,965 | +33.64% | ||
2022-05-16 | Lecault Veronique | Chief Operating Officer | 200,000 0.057% | $6.34 | $1.27M | +31.24% | ||
2022-05-13 | Thermopylae Holdings Ltd. | 10 percent owner | 300,000 0.1057% | $7.26 | $2.18M | +41.77% | ||
2022-05-12 | Thermopylae Holdings Ltd. | 10 percent owner | 1.41M 0.4723% | $6.41 | $9.02M | +52.76% | ||
2022-05-12 | Booth Andrew | Chief Financial Officer | 85,000 0.0258% | $5.79 | $492,150 | +52.76% |
Thermopylae Holdings Ltd. | 10 percent owner | 56143640 18.8409% | $141.48M | 11 | 1 | +6.35% |
Montalbano John S. | director | 171000 0.0574% | $430,920.00 | 8 | 0 | <0.0001% |
THIEL PETER | director | 10179880 3.4162% | $25.65M | 1 | 0 | <0.0001% |
Lecault Veronique | Chief Operating Officer | 2040122 0.6846% | $5.14M | 4 | 1 | <0.0001% |
Hayden Michael R | director | 1323397 0.4441% | $3.33M | 3 | 1 | <0.0001% |
$3,596,906 | 112 | 13.42% | $635.29M | |
$7,929,017 | 58 | 21.56% | $787.18M | |
$97,176 | 41 | 42.84% | $802.16M | |
$94,912,877 | 34 | -7.15% | $626.42M | |
$61,752,931 | 34 | 14.31% | $741.99M |
Increased Positions | 72 | +46.75% | 18M | +15.91% |
Decreased Positions | 59 | -38.31% | 7M | -6.55% |
New Positions | 27 | New | 11M | New |
Sold Out Positions | 16 | Sold Out | 775,526 | Sold Out |
Total Postitions | 167 | +8.44% | 120M | +9.36% |
Baker Bros. Advisors Lp | $71,154.00 | 9.24% | 27.53M | 0 | 0% | 2024-12-31 |
Baillie Gifford & Co | $31,631.00 | 4.11% | 12.24M | -658,238 | -5.11% | 2024-12-31 |
Voya Investment Management Llc | $27,464.00 | 3.57% | 10.62M | 0 | 0% | 2024-12-31 |
Capital World Investors | $20,508.00 | 2.66% | 7.93M | +8M | New | 2024-12-31 |
Prosight Management, Lp | $19,000.00 | 2.47% | 7.35M | -2M | -19.05% | 2024-12-31 |
Credit Suisse Ag/ | $11,755.00 | 1.53% | 4.55M | -30,935 | -0.68% | 2024-03-31 |
Ubs Am, A Distinct Business Unit Of Ubs Asset Management Ame | $11,633.00 | 1.51% | 4.5M | -90,103 | -1.96% | 2024-12-31 |
Orbimed Advisors Llc | $10,807.00 | 1.4% | 4.18M | 0 | 0% | 2024-12-31 |
Arrowmark Colorado Holdings Llc | $10,612.00 | 1.38% | 4.11M | 0 | 0% | 2024-12-31 |
Blackrock, Inc. | $10,590.00 | 1.38% | 4.1M | +107,951 | +2.71% | 2024-12-31 |